Palouse Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,049
| Closed | -$1.24M | – | 150 |
|
|
2023
Q4 | $1.24M | Buy |
3,049
+12
| +0.4% | +$4.88K | 0.88% | 50 |
|
|
2023
Q3 | $1.06M | Buy |
3,037
+1
| +0% | +$348 | 0.78% | 55 |
|
|
2023
Q2 | $1.07M | Sell |
3,036
-218
| -7% | -$76.7K | 0.75% | 55 |
|
|
2023
Q1 | $1.03M | Sell |
3,254
-931
| -22% | -$293K | 0.69% | 58 |
|
|
2022
Q4 | $39.9M | Sell |
4,185
-281
| -6% | -$2.68M | 2.76% | 11 |
|
|
2022
Q3 | $1.29M | Sell |
4,466
-127
| -3% | -$36.8K | 0.73% | 54 |
|
|
2022
Q2 | $1.29M | Sell |
4,593
-1,803
| -28% | -$508K | 0.64% | 59 |
|
|
2022
Q1 | $1.67M | Sell |
6,396
-222
| -3% | -$57.9K | 0.73% | 56 |
|
|
2021
Q4 | $1.45M | Sell |
6,618
-1,090
| -14% | -$239K | 0.62% | 59 |
|
|
2021
Q3 | $1.4M | Sell |
7,708
-227
| -3% | -$41.2K | 0.62% | 59 |
|
|
2021
Q2 | $1.6M | Buy |
7,935
+140
| +2% | +$28.2K | 0.7% | 58 |
|
|
2021
Q1 | $1.68M | Buy |
7,795
+2,434
| +45% | +$523K | 0.74% | 54 |
|
|
2020
Q4 | $1.27M | Buy |
+5,361
| New | +$1.27M | 0.67% | 58 |
|